- Home
- Personal stories
Personal stories
What you need to know about Johnson & Johnson’s 2022 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Securing the future of surgery, one staple at a time
Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.
Meet 7 people who inspired us in 2022
Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.
4 things we now know about hip replacement surgery
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.
How shared accountability can increase the social impact of healthcare investing
Delivering real impact that improves health outcomes for underserved communities requires innovators and investors to make their expectations and standards explicit and then to share a sense of accountability to those expectations.
This award-winning technology is improving disaster relief efforts across the globe
Building on a valued, 15-year collaboration, Johnson & Johnson and International Health Partners proudly debut a shared global donation platform to help communities in crisis recover, rebuild and regain resilience after disasters.
What happens when antibiotics stop working?
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
Improving access to medicine around the world
Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company’s longstanding commitment to make lifesaving medicine available and accessible to those who need it most.
What are autoantibodies?
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
